 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Photogen Technologies, Inc.
 |
Photogen Technologies, Inc. |
 |
 |
 |
PROFILE |
 |
Photogen Technologies takes an enlightened approach to health care. The development-stage company is working on photodynamic therapies that use electromagnetic energy (such as light or X-rays) at specific wavelengths to activate chemical reactions that can destroy diseased cells, remove tissue, or diagnose disease. The company is concentrating research and development in two areas: psoriasis and lymphography, the imaging and diagnosis of lymph nodes. Photogen plans to extend applications of its technology to treat related ailments such as breast, lung, and head cancer, as well as Barrett's esophagus, a pre-cancerous condition. The firm and partner Elan are developing a lymph node imaging agent.
COMPETITION |
 |
DUSA Pharmaceuticals, Inc. (DUSA)
Miravant Medical Technologies (MRVT)
QLT Inc. (QLTI)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: (50.0)%
Employees: 14
Revenue per employee: $7,142.86
KEY PEOPLE |
 |
Taffy J. Williams
CEO
Brooks Boveroux
CFO
CONTACT INFO |
 |
7327 Oak Ridge Hwy., Ste. B
Knoxville, TN 37931
US
Phone: 865-769-4011
Fax: 865-539-9654
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |